收藏切换
Advances in the role of kynurenine 3-monooxygenase in disease and its target drugs
收藏切换
PDF
Yi WANG, Wei WEI*, Yan CHANG*
Acta Pharmaceutica Sinica | 2024, 59(5) : 1101 - 1112
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(5): 1101-1112
Reviews
Advances in the role of kynurenine 3-monooxygenase in disease and its target drugs
Full
Yi WANG, Wei WEI*, Yan CHANG*
Affiliations
  • Clinical Pharmacology Research Institute of Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Drugs of the Ministry of Education, Anhui Province Anti-inflammatory and Immune Drug Collaborative Innovation Center, Anhui Medical University Rheumatoid Arthritis Research Center, Hefei 230000, China
Published: 2024-05-12 doi: 10.16438/j.0513-4870.2023-1236
Outline
收藏切换

Kynurenine 3-monooxygenase (KMO) is a key rate-limiting enzyme in the downstream catabolism of kynurenine pathway (KP). Under the catalysis of KMO, the intermediate product kynurenine is metabolized into various active metabolites, including 3-hydroxykynurenine (3-HK), quinolinic acid (QA) and nicotinamide adenine dinucleotide (NAD+). More and more studies have shown that abnormal KMO expression activity mediates KP metabolic disorders, and is involved in the occurrence and development of nervous system diseases, autoimmune diseases, infectious diseases and tumors, suggesting that KMO can be used as a potential and effective drug therapeutic target. This article focuses on the role of KMO in the pathological mechanism of various diseases, and summarizes the existing KMO inhibitors to provide methods and ideas for targeted KMO therapy.

kynurenine 3-monooxygenase  /  kynurenine pathway  /  tumour  /  nervous system  /  immune system
Yi WANG, Wei WEI, Yan CHANG. Advances in the role of kynurenine 3-monooxygenase in disease and its target drugs[J]. Acta Pharmaceutica Sinica, 2024 , 59 (5) : 1101 -1112 . DOI: 10.16438/j.0513-4870.2023-1236
Year 2024 volume 59 Issue 5
PDF
749
609
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2023-1236
  • Receive Date:2023-11-02
  • Online Date:2025-11-27
  • Published:2024-05-12
Article Data
Affiliations
History
  • Received:2023-11-02
  • Revised:2024-02-05
Funding
Affiliations
    Clinical Pharmacology Research Institute of Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Drugs of the Ministry of Education, Anhui Province Anti-inflammatory and Immune Drug Collaborative Innovation Center, Anhui Medical University Rheumatoid Arthritis Research Center, Hefei 230000, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-1236
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT